Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vapor Group, Inc. is a publicly traded company that develops and commercializes high-bioavailability health and wellness products, with a primary focus on the CBD and hemp sectors. The company utilizes a proprietary sub-micron nanotechnology delivery system designed to enhance the absorption and efficacy of active ingredients such as cannabinoids. Through its flagship brand, Simple Garden CBD, the company offers a range of consumer products including tinctures, topicals, and edibles targeted at pain management and anxiety relief. Originally a player in the electronic cigarette industry, Vapor Group has pivoted to apply its delivery technologies to the broader nutraceutical and biotechnology markets. The company aims to differentiate itself by providing faster-acting formulations compared to standard oil-based CBD products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vapor Group.